Zeke Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Zeke Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$866K	Sell	12,034 -851	-7%	-$64.2K	0.06%	159
2022 Q3	$916K	Sell	12,885 -19	-0.1%	-$1.38K	0.07%	130
2022 Q2	$994K	Buy	12,904 +859	+7%	+$65.4K	0.07%	126
2022 Q1	$879K	Buy	+12,045	New	+$809K	0.04%	156
2020 Q1	–	Sell	-18,557	Closed	-$1.19M	–	273
2019 Q4	$1.19M	Buy	18,557 +11,038	+147%	+$632K	0.1%	169
2019 Q3	$381K	Sell	7,519 -18,757	-71%	-$882K	0.03%	407
2019 Q2	$1.19M	Sell	26,276 -76	-0.3%	-$3.54K	0.11%	155
2019 Q1	$1.26M	Sell	26,352 -1,715	-6%	-$85.4K	0.12%	149
2018 Q4	$1.46M	Buy	28,067 +5,095	+22%	+$274K	0.14%	132
2018 Q3	$1.43M	Sell	22,972 -1,884	-8%	-$112K	0.12%	161
2018 Q2	$1.38M	Sell	24,856 -19,071	-43%	-$1.03M	0.13%	136
2018 Q1	$2.78M	Buy	43,927 +10,675	+32%	+$687K	0.26%	70
2017 Q4	$2.04M	Buy	33,252 +2,283	+7%	+$143K	0.21%	78
2017 Q3	$1.97M	Buy	30,969 +15,189	+96%	+$887K	0.27%	64
2017 Q2	$879K	Buy	15,780 +1,814	+13%	+$98.7K	0.17%	80
2017 Q1	$759K	Buy	13,966 +1,091	+8%	+$59.8K	0.16%	76
2016 Q4	$752K	Buy	12,875 +7,050	+121%	+$385K	0.2%	59
2016 Q3	$287K	Buy	+5,825	New	+$374K	0.13%	59
2015 Q2	–	Sell	-3,313	Closed	-$214K	–	52
2015 Q1	$214K	Buy	+3,313	New	+$207K	0.17%	62
2014 Q1	–	Sell	-4,507	Closed	-$240K	–	59
2013 Q4	$240K	Hold	4,507	–	–	0.22%	50
2013 Q3	$209K	Sell	4,507 -500	-10%	-$21.9K	0.2%	54
2013 Q2	$224K	Buy	+5,007	New	+$217K	0.18%	38

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Zeke Capital Advisors's BMY Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 6.6% in Q4 2022, selling an estimated $64.2K and leaving 12,034 shares worth $866K. The position accounts for 0.06% of the portfolio, ranked #159.

Zeke Capital Advisors first reported a position in BMY in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.78M in Q1 2018. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Zeke Capital Advisors held 12,034 shares of Bristol-Myers Squibb worth $866K as of Q4 2022.
Zeke Capital Advisors sold 851 Bristol-Myers Squibb shares in Q4 2022, an estimated $64.2K.
Bristol-Myers Squibb made up 0.06% of Zeke Capital Advisors's portfolio in Q4 2022, its #159 holding.
Zeke Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 22 quarters since.
Zeke Capital Advisors's Bristol-Myers Squibb position peaked at $2.78M in Q1 2018.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.